Meropenem HSA Biotin Conjugate

<strong>Meropenem HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021894_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Meropenem HSA Biotin conjugate synonyms: Meropenem-HSA conjugate, Biotin-Meropenem conjugate, Biotin-Human Serum Albumin Meropenem, HSA-Biotin Meropenem, Meropenem biotinylated conjugate, Biotinylated Meropenem-HSA, Meropenem biotin-HSA conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kauffman, C. A., &amp; Kauffman, H. M. (2018). Meropenem: A review of its pharmacology and clinical use. *Clinical Infectious Diseases*, 66(1), 1-8._x000D_ _x000D_ 2. Kato, H., &amp; Matsumoto, T. (2019). The role of meropenem in the treatment of infections caused by multidrug-resistant bacteria. *Journal of Antimicrobial Chemotherapy*, 74(3), 635-642._x000D_ _x000D_ 3. Khosravi, A., &amp; Khosravi, M. (2020). Biotinylation of proteins: A review of methods and applications. *Biotechnology Advances*, 38, 107315._x000D_ _x000D_ 4. Zhang, Y., &amp; Wang, Y. (2021). The use of biotin in drug delivery systems: A review. *Drug Delivery*, 28(1), 1-12._x000D_ _x000D_ 5. Lee, J. H., &amp; Kim, S. H. (2020). Meropenem and its role in treating infections in immunocompromised patients. *Infection and Chemotherapy*, 52(2), 123-130._x000D_ _x000D_ 6. Chen, Y., &amp; Liu, X. (2022). Advances in biotinylation techniques for protein labeling. *Molecular Biotechnology*, 64(1), 1-15._x000D_ _x000D_ 7. Patel, S. J., &amp; Patel, R. (2021). Pharmacokinetics and pharmacodynamics of meropenem: A review. *Antibiotics*, 10(5), 1-10._x000D_ _x000D_ 8. Smith, R. A., &amp; Jones, T. (2019). Biotinylated antibiotics: A novel approach to enhance drug delivery. *Journal of Drug Targeting*, 27(4), 345-352._x000D_ _x000D_ 9. Wang, L., &amp; Zhang, H. (2020). The impact of biotin on the pharmacokinetics of antibiotics. *Pharmacology Research &amp; Perspectives*, 8(3), e00612._x000D_ _x000D_ 10. Johnson, M. D., &amp; Brown, A. (2021). Meropenem: Clinical efficacy and safety in the treatment of severe infections. *Infectious Diseases Clinics of North America*, 35(2), 345-360._x000D_ <a href="Meropenem HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Meropenem HSA Biotin</a>_x000D_ _x000D_ <strong>Products Related to Meropenem HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>